ACR Open Rheumatology

Scope & Guideline

Connecting the global rheumatology community through unrestricted access.

Introduction

Immerse yourself in the scholarly insights of ACR Open Rheumatology with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN-
PublisherWILEY
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationACR OPEN RHEUMATOL / ACR Open Rheumatol.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

ACR Open Rheumatology aims to advance the understanding and treatment of rheumatic diseases through rigorous research and scholarly communication. The journal encompasses a wide range of topics related to rheumatology, emphasizing the importance of clinical practice, patient-oriented research, and innovative methodologies.
  1. Clinical and Translational Research:
    The journal publishes studies that bridge laboratory research and clinical practice, focusing on the mechanisms of rheumatic diseases and their treatments.
  2. Patient-Centered Outcomes:
    Research highlighting patient-reported outcomes, quality of life, and treatment adherence is emphasized, showcasing the importance of patient perspectives in rheumatology.
  3. Innovative Therapeutics and Interventions:
    The journal includes studies on new drugs, biologics, and therapeutic interventions, providing insights into efficacy, safety, and practical applications.
  4. Epidemiology and Health Disparities:
    Research addressing the epidemiology of rheumatic diseases, including risk factors, comorbidities, and disparities in care, is a core focus.
  5. Diagnostic and Imaging Advances:
    The journal features studies on novel diagnostic techniques and imaging modalities that enhance the understanding and management of rheumatic conditions.
  6. Health Services and Policy Research:
    Research on healthcare delivery, policy implications, and the economic burden of rheumatic diseases is included to inform practice and improve patient care.
ACR Open Rheumatology has demonstrated a dynamic evolution in its focus areas, reflecting the changing landscape of rheumatology. Recent publications indicate emerging trends and themes that are gaining traction.
  1. Digital Health and Telemedicine:
    With the rise of telehealth, studies exploring the efficacy and patient satisfaction of remote care models have increased significantly, particularly in response to the COVID-19 pandemic.
  2. Mental Health and Psychosocial Aspects:
    There is a growing emphasis on the psychosocial dimensions of rheumatic diseases, including mental health impacts, which are increasingly recognized as crucial in patient care.
  3. Integrative and Complementary Therapies:
    Research exploring the use of complementary and integrative therapies alongside traditional treatments is on the rise, reflecting patient interest in holistic care.
  4. Machine Learning and Data Analytics:
    The application of machine learning techniques for predicting outcomes and personalizing treatments is emerging as a significant area of research.
  5. Health Disparities and Social Determinants of Health:
    There is an increasing focus on understanding how social determinants affect the incidence, treatment access, and outcomes for patients with rheumatic diseases.
  6. Patient Empowerment and Shared Decision-Making:
    Studies promoting patient involvement in treatment decisions and self-management strategies are gaining importance, highlighting a shift towards more patient-centered care.

Declining or Waning

While ACR Open Rheumatology continues to cover a broad range of topics, certain areas have shown a decline in publication frequency or emphasis in recent years. The following themes appear to be waning.
  1. Traditional Pharmacotherapy Studies:
    There has been a noticeable decline in studies focusing solely on conventional disease-modifying antirheumatic drugs (DMARDs) without the integration of newer therapies or comparative effectiveness research.
  2. Basic Science Research:
    The journal has shifted towards more clinically relevant studies, leading to a decrease in purely basic science research that does not directly relate to patient outcomes.
  3. Single-Center Studies:
    There is a trend away from publication of single-center studies, with a preference for multi-center collaborations that enhance the generalizability of findings.
  4. Longitudinal Cohort Studies without Intervention:
    While cohort studies remain important, those that do not investigate interventions or outcomes have decreased, reflecting a broader interest in actionable research.
  5. Focus on Rare Diseases:
    Research on rare rheumatic conditions, while still valuable, has seen a decrease in frequency, possibly due to the growing interest in more prevalent diseases or conditions.

Similar Journals

Current Rheumatology Reports

Pioneering insights into rheumatological diseases.
Publisher: SPRINGERISSN: 1523-3774Frequency: 12 issues/year

Current Rheumatology Reports is a premier journal dedicated to advancing the field of rheumatology, published by Springer. With an esteemed Q1 category ranking in Rheumatology as of 2023 and a remarkable Scopus rank of 6 out of 73, this journal stands at the forefront of research dissemination, boasting an impressive percentile ranking in the 92nd. Since its inception in 1999, Current Rheumatology Reports has provided a critical platform for the latest findings in rheumatological diseases, treatment strategies, and clinical practices. Although it currently does not offer Open Access options, the journal's rigorous peer-review process ensures high-quality publications that are essential for researchers, clinicians, and students alike. By keeping the community informed of key developments, this journal plays a vital role in shaping contemporary rheumatological research and practice, thereby facilitating the advancement of patient care worldwide.

RMD Open

Leading the way in open-access rheumatology research.
Publisher: BMJ PUBLISHING GROUPISSN: 2056-5933Frequency: 2 issues/year

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY

Advancing Clinical Excellence in Rheumatology
Publisher: ELSEVIER SCI LTDISSN: 1521-6942Frequency: 4 issues/year

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, published by Elsevier, stands as a premier journal in the field of rheumatology, holding a prestigious Q1 ranking in both Medicine (miscellaneous) and Rheumatology categories as of 2023. With an ISSN of 1521-6942 and an E-ISSN of 1521-1770, the journal is dedicated to advancing clinical knowledge and practice through the dissemination of high-quality, peer-reviewed research. Since its inception in 1995, this journal has provided a platform for researchers, clinicians, and healthcare providers to share significant advancements, best practices, and innovative insights that shape the standards of care in rheumatology. The commitment to open access publishing reflects its mission to broaden the reach of critical research findings, ensuring that professionals across the globe can access valuable information in this vital field. The journal's impressive Scopus ranking, positioned at #10 out of 73 in Medicine-Rheumatology, alongside its notable impact factor, underscores its importance and influence in guiding clinical practice and policy in rheumatologic conditions. By engaging with this journal, readers can stay informed about emerging trends and evidence-based strategies that are crucial for improving patient outcomes.

Rheumatology Advances in Practice

Empowering rheumatology through innovation and education.
Publisher: OXFORD UNIV PRESSISSN: Frequency: 2 issues/year

Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.

Indian Journal of Rheumatology

Connecting researchers and practitioners in the realm of rheumatology.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

Reumatologia

Advancing knowledge in Rheumatology and Immunology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Advances in Rheumatology

Fostering collaboration for cutting-edge rheumatological advancements.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.

Open Access Rheumatology-Research and Reviews

Empowering Researchers with Open Access Insights.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

Archives of Rheumatology

Fostering collaboration and discovery in rheumatology.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

Lancet Rheumatology

Unveiling the latest breakthroughs in rheumatological research.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.